Almac’s North Carolina Facility Continues Growth in Academically based Clinical Trials

06-May-2010 - USA

Almac Clinical services, has seen a continued growth from clients operating in the not- for-profit sector on academically based clinical trials. The site in Durham which recently doubled capacity and passed an FDA inspection, also operates as a licensed pharmacy. The unit was originally part of the Duke Clinical Research Institute from 1990-2000 with all of the studies handled during this time were physician-led and academically based.

Donna Christopher, VP of Operations at Almac Clinical Services, Durham Facility commented ‘As our business continues to evolve under the Almac brand we have stayed close to our roots in academically based clinical trials - an area where our expertise lies. Alongside our core contract services, we also advise many of our clients on how to conduct their trials. From the outset we provide information on clinical input, study materials required, efficient drug kits design as well as full supply chain management in addition to providing training and monitoring to sites. We work together with our Academic clients to ensure their clinical trials are run to maximum efficiency enabling them to focus solely on their trial results. In recent months we have doubled our capacity to enable us to meet the increased demands for our services.”

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

Last viewed contents

Researchers find possible genetic link for pelvic floor disorders - Gene on chromosome 9 may predispose some women to pelvic floor defects

Sanofi and Regeneron Launch Major New Immuno-Oncology Collaboration - Companies agree to jointly advance PD-1 and other new immuno-oncology antibodies

Cellzome Receives First Milestone Payment for Alzheimer's Program from Ortho-McNeil Pharmaceutical, Inc.

From Regional to Global: How Pfizer reworked the pharmaceutical business model

Your brain digitally remastered for clarity of thought - Neurofeedback can enhance the signal-to-noise ratio in thought, enabling a sharper focus on tasks

Nelson M. Sims joins Aastrom Biosciences' Board of Directors

Oncolytics Biotech Inc. Appoints Senior Vice President, Global Licensing and Business Development

EKF Diagnostics acquires Selah Genomics and DiaSpect Medical AB

Oncolytics Biotech Inc. Research Collaborators Demonstrate Reovirus/Gemcitabine Combination Has Synergistic Effect

Kiel Möbius Prize goes to renowned American microbiome researcher

Kiel Möbius Prize goes to renowned American microbiome researcher

Innovative Roche cancer medicine Avastin approved in EU - First Treatment of its Kind With Proven Survival Benefit for Patients With Advanced Colorectal Cancer

Eindhoven University of Technology opens new incubator facility for breakthrough research - Institute for Complex Molecular Systems gets new accommodation in an architecturally and historically special building

Eindhoven University of Technology opens new incubator facility for breakthrough research - Institute for Complex Molecular Systems gets new accommodation in an architecturally and historically special building